Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
source: pixabay.com

Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis

A study reported in NewsWise evaluates retinoid-x receptor (RXR) agonists as a treatment for recurring and refractory multiple sclerosis (MS). This specific RXR agonist, bexarotene, was found to help remyelination,…

Continue Reading Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
source: pixabay.com

1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases

Leszek Ignatowicz, a researcher from Georgia State University, recently received a 5 year, almost 2 million dollar grant from the NIH for his investigation into multiple sclerosis (MS). This project…

Continue Reading 1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment
source: pixabay.com

Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment

According to a story from Multiple Sclerosis News Today, the drug company Bristol-Myers Squibb recently announced that its drug ozanimod (marketed as Zeposia) is now available for public use in…

Continue Reading Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment

Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis

The European Commission has recently granted approval to Bristol Myers Squibb (BMS) for their multiple sclerosis (MS) treatment, Zeposia. It has already been approved by the FDA in the US…

Continue Reading Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis

Scientists Have Discovered a New Approach to Diagnosing Multiple Sclerosis

Scientists at the Tohoku University reported in Asia Research News that antibodies are responsible for the difference between various disorders and multiple sclerosis (MS). These disorders affect the myelin sheath…

Continue Reading Scientists Have Discovered a New Approach to Diagnosing Multiple Sclerosis
A New and Beneficial Tactic for People with Multiple Sclerosis? Mindfulness Training
Photo by Dingzeyu Li on Unsplash

A New and Beneficial Tactic for People with Multiple Sclerosis? Mindfulness Training

Being at peace with ourselves and our lives makes daily living so much easier. Of course, sometimes it's easier said than done. But one tactic may help improve comfort, confidence,…

Continue Reading A New and Beneficial Tactic for People with Multiple Sclerosis? Mindfulness Training
Close Menu